RUBIN PAUL D
SEC insider (Form 3/4/5 filer). CIK 0001210905. Chief Medical Officer at BioAge Labs, Inc. (BIOA). 18 reported Form 4/5 transactions since Sep 2024; latest on Apr 1, 2026. Located in EMERYVILLE, CA.
Companies RUBIN PAUL D has filed insider reports for
- BioAge Labs, Inc. (BIOA): Officer, Chief Medical Officer
RUBIN PAUL D
CIK: 0001210905
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BioAge Labs, Inc.
Discretionary Trading P&L
Holdings
Transaction History (18 total)
- Apr 1, 2026BIOA
BioAge Labs, Inc.
ExerciseDirect3.4K shares at avg. $6.57$22K - Apr 1, 2026BIOA
BioAge Labs, Inc.
SaleDirect8.8K shares at avg. $17.81$157K - Apr 1, 2026BIOA
BioAge Labs, Inc.
ExerciseDirect5.4K shares at avg. $4.11$22K - Mar 2, 2026BIOA
BioAge Labs, Inc.
ExerciseDirect2K shares at avg. $6.57$13K - Mar 2, 2026BIOA
BioAge Labs, Inc.
SaleDirect7.4K shares at avg. $20.30$151K - Mar 2, 2026BIOA
BioAge Labs, Inc.
ExerciseDirect5.4K shares at avg. $4.11$22K - Feb 17, 2026BIOA
BioAge Labs, Inc.
AwardDirectStock Option (Right to Buy)
110K shares- - Feb 2, 2026BIOA
BioAge Labs, Inc.
SaleDirect7.4K shares at avg. $18.75$139K - Feb 2, 2026BIOA
BioAge Labs, Inc.
ExerciseDirect5.4K shares at avg. $4.11$22K - Feb 2, 2026BIOA
BioAge Labs, Inc.
ExerciseDirect2K shares at avg. $6.57$13K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 1, 2026 | BIOA BioAge Labs, Inc. | Exercise | 3,383 | $6.57 | $22,226 | Direct |
| Apr 1, 2026 | BIOA BioAge Labs, Inc. | Sale | 8,820 | $17.81 | $157,084 | Direct |
| Apr 1, 2026 | BIOA BioAge Labs, Inc. | Exercise | 5,437 | $4.11 | $22,346 | Direct |
| Mar 2, 2026 | BIOA BioAge Labs, Inc. | Exercise | 2,000 | $6.57 | $13,140 | Direct |
| Mar 2, 2026 | BIOA BioAge Labs, Inc. | Sale | 7,433 | $20.30 | $150,890 | Direct |
| Mar 2, 2026 | BIOA BioAge Labs, Inc. | Exercise | 5,433 | $4.11 | $22,330 | Direct |
| Feb 17, 2026 | BIOA BioAge Labs, Inc. | Award Stock Option (Right to Buy) | 110,000 | - | - | Direct |
| Feb 2, 2026 | BIOA BioAge Labs, Inc. | Sale | 7,433 | $18.75 | $139,369 | Direct |
| Feb 2, 2026 | BIOA BioAge Labs, Inc. | Exercise | 5,433 | $4.11 | $22,330 | Direct |
| Feb 2, 2026 | BIOA BioAge Labs, Inc. | Exercise | 2,000 | $6.57 | $13,140 | Direct |
1-10 of 18 transactions